Acutus Medical Stock (NASDAQ: AFIB) stock price, news, charts, stock research, profile.
Open | $0.166 |
Close | $0.162 |
Volume / Avg. | 390.222K / 1.114M |
Day Range | 0.160 - 0.170 |
52 Wk Range | 0.160 - 1.090 |
Market Cap | $4.977M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 2.9% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acutus Medical (NASDAQ: AFIB) through any online brokerage.
Other companies in Acutus Medical’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL) and Venus Concept (NASDAQ:VERO).
The latest price target for Acutus Medical (NASDAQ: AFIB) was reported by Goldman Sachs on Tuesday, August 16, 2022. The analyst firm set a price target for 1.50 expecting AFIB to rise to within 12 months (a possible 795.52% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acutus Medical (NASDAQ: AFIB) is $0.1675 last updated Today at April 29, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Acutus Medical.
Acutus Medical’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Acutus Medical.
Acutus Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.